Clinical Trials in San Antonio

Showing 2641-2660 of 12,572 trials

Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

NCT05380401

A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.

Premature

The University of Texas Health Science Center at San Antonio328 participantsStarted Mar 2023

Los Angeles, California, United States • New Haven, Connecticut, United States • Chicago, Illinois, United States +4 more locations

COMPLETEDPhase 3< 1 mile

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

NCT05587309

The objective of the Healing Phase of the study is to evaluate the safety and efficacy of up to 8 weeks of once daily oral administration of BLI5100 versus a PPI control in healing EE. The objective of the Maintenance Phase of the study is to evaluate the safety and efficacy of 24 weeks of once daily oral administration of BLI5100 (low or high dose) versus a PPI control in the maintenance of healed EE.

Erosive Esophagitis

Braintree Laboratories1,250 participantsStarted Oct 2022

Homewood, Alabama, United States • Huntsville, Alabama, United States • Peoria, Arizona, United States +119 more locations

Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

Find Trials by Condition in San Antonio

A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy Participants

Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

4D-150 in Patients With Diabetic Macular Edema

Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

R-2487 in Patients With Rheumatoid Arthritis

CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative

A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)